Biosimilars in Healthcare Economics: Enhancing Global Access to Medicine Date: July 2025 Healthcare systems globally are facing unprecedented economic
Introduction: Biomanufacturing in the GCC Enters a New Era As the Gulf Cooperation Council (GCC) nations advance their healthcare and
Introduction: The Strategic Rise of Bio Pharma in the GCC The Gulf Cooperation Council (GCC) nations are experiencing a dynamic
Chimeric antigen receptor T-cell (CAR-T) therapy has become a cornerstone in the treatment of relapsed or refractory aggressive B-cell lymphomas,
Imagine turning a patient’s immune cells into a personalized “search-and-destroy” squad that hunts cancer wherever it hides. That vision, once
The prohibitive cost and complexity of ex vivo gene therapies, such as CAR-T cell production, have long been significant barriers
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
